Search for: "AstraZeneca Pharmaceuticals, LP"
Results 61 - 80
of 116
Sort by Relevance
|
Sort by Date
15 Feb 2011, 4:06 am
AstraZeneca LP, 605 F.Supp.2d 669, 678-79 (W.D.Pa.2009) (discussing why the “professional paradigm” places the physician as the relevant decision maker in the health services industry), aff’d on other grounds, 372 Fed. [read post]
26 Jan 2011, 1:31 am
In April of last year, we obtained a $520 million settlement with AstraZeneca LP and AstraZeneca Pharmaceuticals LP to resolve allegations that marketing of the anti-psychotic drug Seroquel for uses not approved as safe and effective by the FDA caused false claims to be submitted to federal health care programs. [read post]
29 Dec 2010, 12:54 pm
In a transparent attempt to hamstring pharmaceutical marketing, the state of Vermont made it illegal for data miners to sell physician prescribing information to pharmaceutical companies. [read post]
1 Dec 2010, 12:15 am
Navinta LLC (Property, intangible) Pulmicort Respules (Budesonide) – US: Liability for future indirect infringement: AstraZeneca LP v. [read post]
23 Nov 2010, 1:00 am
By Jason Rantanen In an earlier post, I summarized the Federal Circuit's affirmance of a preliminary injunction prohibiting Apotex from marketing its generic version of AstraZeneca's budesonide in AstraZeneca LP v. [read post]
3 Nov 2010, 5:56 am
Astrazeneca Pharmaceuticals LP, et. al., 2-08-cv-04786 (PAED October 20, 2010, Memorandum and/or Opinion) (Yohn, J.) [read post]
6 Oct 2010, 7:46 am
AstraZeneca LP, 372 F. [read post]
3 Oct 2010, 8:57 pm
Astrazeneca Pharmaceuticals LP... [read post]
24 Sep 2010, 7:00 am
Goldfield, Civil Action No. 10-CV-4430-ER (E.D.P.A.): In this case, the SEC alleges that Self, an Executive Director of Business Development at a pharmaceutical company and Goldfield, a former hedge fund manager, engaged in unlawful insider trading in advance of the April 23, 2007 announcement that AstraZeneca would acquire MedImmune, Inc. [read post]
25 Aug 2010, 12:37 am
Osmotica Pharmaceutical Corp (Patent Docs) Seroquel (Quetiapine) – US: Patent infringement suit filed following Para IV certification: Astrazeneca Pharmaceuticals LP et al. v. [read post]
10 Aug 2010, 6:10 am
Astrazeneca Pharmaceuticals LP, 585 F. [read post]
30 Jul 2010, 4:06 am
In Smith, the Third Circuit held that a pharmaceutical sales representative was not entitled to overtime pay because she qualified for the administrative exemption under the FLSA. [read post]
28 Jul 2010, 12:06 am
(Patent Docs) Crestor (Rosuvastatin) – US: Patent infringement complaint following amended ANDA filing: AstraZeneca Pharmaceuticals LP et al. v. [read post]
20 Jul 2010, 12:58 pm
In April of 2010, AstraZeneca LP and AstraZeneca Pharmaceuticals agreed to pay $520 million to resolve claims that the company marketed the drug Seroquel for off-label purposes and provided kick-backs to doctors who promoted its use. [read post]
2 Jul 2010, 5:28 am
LP et al v. [read post]
30 Jun 2010, 5:52 am
Mylan Pharmaceuticals Inc. et al. [read post]
29 Jun 2010, 6:01 pm
Mylan Pharmaceuticals Inc. et al. [read post]
27 Jun 2010, 9:11 pm
AstraZeneca Pharmaceuticals LP et al. v. [read post]
27 May 2010, 3:20 am
AstraZeneca Pharmaceuticals LP et al. [read post]
13 May 2010, 12:27 pm
Astrazeneca Pharmaceuticals LP, 2009 WL 2231686 (M.D. [read post]
